TORINO, Italy--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today that it has entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of PAI ...
Live audiovisual webcasts of the presentations will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. Replays of the presentations will be posted in the ...
Bruker Corporation (Nasdaq: BRKR) today announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue and disease models for drug discovery and ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Bruker operates in a duopoly with Thermo Fisher, serving critical life sciences and industrial markets, with diversified revenue and growing recurring sales. Despite macro headwinds and NIH budget ...
BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (NASDAQ: BRKR) has been selected as the Instrument Business Outlook (IBO) ‘Company of the Year’ for 2023. IBO cited Bruker’s double-digit organic ...
PhenomeX was formed in early 2023 through the combination of Berkeley Lights and IsoPlexis, and PhenomeX currently has an installed base of more than 400 instruments. PhenomeX provides single-cell ...
At ASMS, Bruker Corporation (Nasdaq: BRKR) announced the launch of the unique timsMRMS system, bringing the power of trapped ion mobility separation to ultra-high-resolution magnetic resonance mass ...
Good day, ladies and gentlemen, and welcome to the Bruker Corporation Quarterly Earnings Call hosted by Stacey Desrochers. My name is Geoff and I'm your event manager. During the presentation your ...
Hosted on MSN
Wells Fargo Maintains Bruker Corporation - Preferred Stock (BRKRP) Overweight Recommendation
Fintel reports that on November 5, 2025, Wells Fargo maintained coverage of Bruker Corporation - Preferred Stock (NasdaqGS:BRKRP) with a Overweight recommendation. Analyst Price Forecast Suggests ...
US PTAB Revokes Sole Independent and Other Central Claims of U.S. Patent 11,435,360 PreOmics GmbH and Biognosys AG today announced a favorable outcome in an inter partes review (IPR) proceeding IPR202 ...
MIMETAS' unique organ-on-a-chip and human tissue models complement Bruker's multiomics, NMR, spatial biology and preclinical imaging solutions Bruker Corporation (Nasdaq: BRKR) today announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results